Cargando…
Construction and Characterization of a Recombinant Human Respiratory Syncytial Virus Encoding Enhanced Green Fluorescence Protein for Antiviral Drug Screening Assay
Human respiratory syncytial virus (RSV) is the single most important cause of lower respiratory tract disease in infants and young children and a major viral agent responsible for respiratory tract disease in immunosuppressed individuals and the elderly, but no vaccines and antiviral drugs are avail...
Autores principales: | Xu, Min, Jiao, Yue-Ying, Fu, Yuan-Hui, Jiang, Nan, Zheng, Yuan-Bo, Yan, Yi-Fei, Zhang, Mei, Zheng, Yan-Peng, Zhu, Wu-Yang, Peng, Xiang-Lei, He, Jin-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820570/ https://www.ncbi.nlm.nih.gov/pubmed/29568767 http://dx.doi.org/10.1155/2018/8431243 |
Ejemplares similares
-
Evaluation of the Safety and Immune Efficacy of Recombinant Human Respiratory Syncytial Virus Strain Long Live Attenuated Vaccine Candidates
por: Wang, Li-Nan, et al.
Publicado: (2021) -
Construction of a Recombinant Porcine Epidemic Diarrhea Virus Encoding Nanoluciferase for High-Throughput Screening of Natural Antiviral Products
por: Li, Wan, et al.
Publicado: (2021) -
An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting
por: van Remmerden, Yvonne, et al.
Publicado: (2012) -
Genetic diversity and molecular evolution of human respiratory syncytial virus A and B
por: Yu, Jie-Mei, et al.
Publicado: (2021) -
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay
por: Shambaugh, Cindy, et al.
Publicado: (2017)